Search research articles
Contact Us
Filters
Showing results (1-10 of 11) with videos related to
Page
of 2
Sort By:
Plos One
|
October 8, 2021
Detailing the epidemiological and clinical characteristics of chronic lymphocytic leukaemia in Portugal-Results from a population-based cancer registry cohort study
Fábio Cardoso Borges, Adriana Ramos, António Lourenço, et al.
Scientific Reports
|
April 6, 2023
Epidemiological and clinical characterization of a population-based cohort of cutaneous malignant melanoma patients in the South Region of Portugal
Filipa Alves da Costa, Adriana Ramos, Catarina Bernardo, et al.
Frontiers in Medicine
|
August 29, 2022
A review of patient-reported outcomes used for regulatory approval of oncology medicinal products in the European Union between 2017 and 2020
Maria Manuel Teixeira, Fábio Cardoso Borges, Paula Sousa Ferreira, et al.
Frontiers in Medicine
|
August 6, 2019
Intensive Monitoring Studies for Assessing Medicines: A Systematic Review
Carla Torre, Maria Cary, Fábio Cardoso Borges, et al.
International Journal of Clinical Pharmacy
|
June 4, 2018
Using a cancer registry to capture signals of adverse events following immune and targeted therapy for melanoma
João P Aguiar, Fábio Cardoso Borges, Rodrigo Murteira, et al.
Pharmacoepidemiology and Drug Safety
|
August 27, 2020
Real-world effectiveness of pembrolizumab in previously treated non-small cell lung cancer: A population-based cohort study
Rodrigo Murteira, Fábio Cardoso Borges, Gonçalo Pinto Mendes, et al.
Breast (Edinburgh, Scotland)
|
February 19, 2022
Real-world effectiveness of palbociclib plus fulvestrant in advanced breast cancer: Results from a population-based cohort study
Fábio Cardoso Borges, Filipa Alves da Costa, Adriana Ramos, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
May 17, 2025
Synergizing Needs Assessments and Patient Preference Studies for Enhanced Patient-centred Decision-Making in Healthcare
Elise Schoefs, Alice Vanneste, Alessandra Blonda, et al.
Breast Cancer Research : BCR
|
June 29, 2023
Effectiveness of palbociclib with aromatase inhibitors for the treatment of advanced breast cancer in an exposure retrospective cohort study: implications for clinical practice
Filipa Alves da Costa, Fábio Cardoso Borges, Adriana Ramos, et al.
Journal of Cancer Policy
|
January 9, 2026
Accelerating cancer treatment optimisation: A multistakeholder roadmap from the Cancer Medicines Forum
Denis Lacombe, Fábio Cardoso Borges, Ana E Amariutei, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 11) with videos related to
Sort By:
Page
of 2
Plos One
|
October 8, 2021
Detailing the epidemiological and clinical characteristics of chronic lymphocytic leukaemia in Portugal-Results from a population-based cancer registry cohort study
Fábio Cardoso Borges, Adriana Ramos, António Lourenço, et al.
Scientific Reports
|
April 6, 2023
Epidemiological and clinical characterization of a population-based cohort of cutaneous malignant melanoma patients in the South Region of Portugal
Filipa Alves da Costa, Adriana Ramos, Catarina Bernardo, et al.
Frontiers in Medicine
|
August 29, 2022
A review of patient-reported outcomes used for regulatory approval of oncology medicinal products in the European Union between 2017 and 2020
Maria Manuel Teixeira, Fábio Cardoso Borges, Paula Sousa Ferreira, et al.
Frontiers in Medicine
|
August 6, 2019
Intensive Monitoring Studies for Assessing Medicines: A Systematic Review
Carla Torre, Maria Cary, Fábio Cardoso Borges, et al.
International Journal of Clinical Pharmacy
|
June 4, 2018
Using a cancer registry to capture signals of adverse events following immune and targeted therapy for melanoma
João P Aguiar, Fábio Cardoso Borges, Rodrigo Murteira, et al.
Pharmacoepidemiology and Drug Safety
|
August 27, 2020
Real-world effectiveness of pembrolizumab in previously treated non-small cell lung cancer: A population-based cohort study
Rodrigo Murteira, Fábio Cardoso Borges, Gonçalo Pinto Mendes, et al.
Breast (Edinburgh, Scotland)
|
February 19, 2022
Real-world effectiveness of palbociclib plus fulvestrant in advanced breast cancer: Results from a population-based cohort study
Fábio Cardoso Borges, Filipa Alves da Costa, Adriana Ramos, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
May 17, 2025
Synergizing Needs Assessments and Patient Preference Studies for Enhanced Patient-centred Decision-Making in Healthcare
Elise Schoefs, Alice Vanneste, Alessandra Blonda, et al.
Breast Cancer Research : BCR
|
June 29, 2023
Effectiveness of palbociclib with aromatase inhibitors for the treatment of advanced breast cancer in an exposure retrospective cohort study: implications for clinical practice
Filipa Alves da Costa, Fábio Cardoso Borges, Adriana Ramos, et al.
Journal of Cancer Policy
|
January 9, 2026
Accelerating cancer treatment optimisation: A multistakeholder roadmap from the Cancer Medicines Forum
Denis Lacombe, Fábio Cardoso Borges, Ana E Amariutei, et al.
Page
of 2